Overview
Until recently, the average person with Alström Syndrome wasn't diagnosed until early adulthood — sometimes after years of being labeled with several wrong conditions. That picture is changing. UK data show the average age at diagnosis dropped from around 20 years in 2018 to about 7 years in 2022. Here's what's behind the shift and how to make it work in your family's favor.
The data on diagnosis age
The 2024 Alström Syndrome UK Journey to Diagnosis report tracked newly-referred patients across recent years. The most striking finding was the drop in average age at diagnosis:
- 2018: Average age at diagnosis approximately 20 years
- 2022: Average age at diagnosis approximately 7 years¹
Older retrospective studies of US patients found a similar pattern of long delays — many patients diagnosed in adolescence or adulthood after years of unexplained symptoms.² Recent international cohort studies, including a 2025 Chinese study of 127 patients, show that diagnostic age is also falling outside the UK as awareness improves.³
In the US, about a quarter of children with Alström receive their diagnosis within one year of the first symptom. The most common age range for diagnosis in modern cohorts is 2 to 6 years.
Why diagnosis age was historically so late
Three factors made early diagnosis hard:
1. Awareness gaps. With around 1,200 cases known worldwide, most pediatricians and many specialists never see a case in their career. 2. Single-system presentations. A baby with isolated cardiomyopathy or isolated retinal disease doesn't immediately look syndromic. 3. Limited genetic-testing access. ALMS1 sequencing was expensive and restricted until panel-based testing made it more affordable in the 2010s.
Why the average is dropping
Several changes are pulling the diagnostic age earlier:
Wider, cheaper genetic testing
Multi-gene panels for retinal dystrophies and pediatric cardiomyopathies now routinely include ALMS1. A pediatric cardiologist investigating an infant's dilated cardiomyopathy can order a panel that screens ALMS1 alongside dozens of other cardiomyopathy genes — often returning answers within weeks.⁴
NICU and PICU genomic testing
Rapid trio whole-exome and whole-genome sequencing is increasingly available for critically ill newborns and infants. Programs like NSIGHT, the Rady Children's Rapid Genome program, and similar initiatives have caught Alström at days of life when a baby presented with severe heart failure of unknown cause.
Specialist clinic networks
Multidisciplinary Alström clinics (Greater Baltimore Medical Center, Indiana University, Birmingham Women's & Children's, the European Reference Network for rare eye diseases) now share knowledge and case-recognition patterns. A child seen at any of these centers gets the diagnosis quickly.
Awareness campaigns
Patient organizations including Alström Syndrome International, Alström Syndrome UK, and Alström Angels have run sustained awareness campaigns aimed at pediatricians, pediatric cardiologists, ophthalmologists, and genetic counselors. The 2024 ASUK report explicitly credits these campaigns for the change.¹
How to push for an earlier diagnosis
If you suspect Alström and the diagnosis hasn't been made yet, the steps are:
1. List the features your child has — eye signs, heart issues, hearing concerns, weight pattern, family history. 2. Ask for a referral to clinical genetics. This is the single most useful step. Geneticists know to consider Alström. 3. *Ask whether genetic testing has been ordered and whether ALMS1 is on the panel. Many panels include it — but not all. 4. If only one panel was negative, ask about expanded testing — deletion/duplication analysis, comprehensive ciliopathy panel, whole-exome sequencing. 5. Connect with patient organizations.* ASI and ASUK can help families navigate getting evaluated at a center of excellence.
Why earlier diagnosis matters
An earlier diagnosis directly improves care:
- Cardiomyopathy is detected and treated before complications develop
- Vision-loss preparation (Braille, mobility, assistive tech) can begin while the child still has usable vision
- Hearing loss is monitored and amplification fitted at the right time
- Diabetes and metabolic complications are caught early
- Families can connect with support communities while still in the early phase
- Educational planning can start before kindergarten rather than scrambling later
A 2015 paper on the model of care for Alström noted that patients in highly specialized clinical services have better treatment compliance and clinic attendance compared with standard care.⁵
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
What's the youngest age Alström has been diagnosed?
Answer
Alström can be confirmed at birth or in the first weeks of life if a baby has classic clinical features — typically severe photophobia, nystagmus, or unexplained heart failure — and rapid genetic testing returns ALMS1 mutations. Prenatal diagnosis is also possible when both parents are known carriers.
Question
My child is 8 and just diagnosed. Is that late?
Answer
It's around the current global average. Earlier diagnosis is better, but a diagnosis at age 8 still gives time to plan vision-loss preparation, set up surveillance for the systems not yet involved, and begin educational adaptations.
Question
Are adults still being diagnosed for the first time?
Answer
Yes — particularly adults who grew up before ALMS1 testing was widely available. They may have been diagnosed with separate conditions for years (retinitis pigmentosa, idiopathic cardiomyopathy, severe insulin resistance) before someone connects the dots and orders genetic testing.
Question
Will my insurance pay for genetic testing?
Answer
Most US and UK insurance and national health systems cover genetic testing when there's a reasonable clinical suspicion. Your genetics team will write a letter of medical necessity. If coverage is denied, several patient-assistance programs and the testing labs themselves have funded testing for families with rare diseases.